Collaboration Details

Print  Close


Title of Collaborative Activity:

CMS-NIH Collaborations on CMS Innovation Center

Description of Collaborative Activity:

The Innovation Center aims to test innovative payment and service delivery models to reduce program expenditures under Medicare, Medicaid and CHIP, while preserving or enhancing the quality of care furnished. CMS and NIH have been discussing potential approaches to NIH collaboration with various Innovation Center Initiatives including the Health Care Innovation Challenge and the State Innovation Program. The Health Care Innovation Challenge, released in November 2011, makes up to $1 billion available, and will be awarded to innovative projects testing creative approaches to delivering high-quality health care services, at lower cost, with priority to projects that hire, train, and deploy new types of health care workers. The State Innovation Program (SIIP) FOA was released in January, 2012, offering States the opportunity to participate directly in multi-payer delivery system strategies, and to design models that achieve the radical shift towards prevention. The program aims to accelerate healthcare system transformation and reduce healthcare cost. The initiative has a five year program life cycle with a total budget of $1.3 billion. NIH has proposed high impact areas and results that could be rapidly implemented on larger scales, including: diabetes (i.e. the Diabetes Prevention Program), schizophrenia (i.e. RAISE trial), stroke, lung cancer (i.e. the National Lung Cancer Spiral CT Screening Trial), and prevention of pre-term birth. Currently, CMS and NIH are collaborating to develop randomized controlled clinical policy trials: novel, low cost practical trials that can drive reform. NIH, in collaboration with CMS is developing a PAR on Large, Inexpensive, Pragmatic Randomized Controlled Policy Trials, as a new way to develop evidence-based policy. This solicitation will represent a first steps to jointly leveraging CMS and NIH strengths. Simple, pragmatic trials, with minimal inclusion and exclusion criteria, will assist NIH and CMS in capturing patients similar to the ones seen in everyday practice, and help capture information on large populations with multiple co-morbidities.

Type of Collaborative Activity:

Select Type of Collaborative Activity

Year the Collaborative Activity Originated:

2011

NIH Participating Institutes/Centers/Office of the Director:

CC, NCCAM, NCI, NCATS, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM, OD

HHS Agency Collaborators on this Activity:

CMS